{
    "nct_id": "NCT03796559",
    "official_title": "A Prospective Open Label Study of the Use of Magseed® Markers and Sentimag® to Localize Axillary Lymph Nodes with Biopsy-proven Metastases in Breast Cancer Patients",
    "inclusion_criteria": "* Age 18 years or older at time of consent\n* Histologically confirmed cT0-4, N1 breast cancer\n* Axillary lymph node metastasis with pathologic confirmation by needle biopsy\n* Clip placed in the sampled axillary lymph node before initiation of chemotherapy\n* Planned for neo-adjuvant chemotherapy prior to surgical resection\n* Eligible for targeted axillary dissection (defined as selective localization and removal of the clipped node and SLND) at the completion of neo-adjuvant chemotherapy\n* ECOG performance status 0-2\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Distant metastases\n* Inflammatory breast cancer\n* Prior ipsilateral axillary surgical procedure including SLND or axillary node excision\n* Prior history of breast cancer in the ipsilateral breast\n* History of lymphoma\n* Subject is pregnant\n* Previous radiation to the breast or axilla\n* Pacemaker or other implantable cardiac device in the ipsilateral chest wall",
    "miscellaneous_criteria": ""
}